{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:38:46Z","timestamp":1787164726533,"version":"build-2736575974"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":475,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The main purpose of this project was to capture experts' opinion on hyperkalaemia management and form best practice recommendations for cardiorenal patients in Greece. A steering committee of nephrologists and cardiologists developed 37 statements. An online questionnaire completed by 32 experts in cardiorenal management in Greece. Median score used to determine the level of agreement and disagreement index (DI) used to determine the level of consensus for each statement. Statements divided in four sectors: hyperkalaemia risk management, preventative measures, treatment and collaboration between specialties. The rate of the first round of the consensus was 94.6%. Median score was &amp;gt;7 for 36 of 37 statements and DI \u2264 1 for 35 of 37. Among other statements, consensus reached for recognizing levels K+ &amp;gt; 5.0 mEq\/L as associated with elevated mortality risk; retaining renin\u2013angiotensin\u2013aldosterone system inhibitors (RAASi) on maximum recommended dose for cardiorenal patients; and using novel K+ binders to help enabling guideline-recommended doses of RAASi therapy. Cardiologists compared to nephrologists showed higher reluctance to discontinue down-titrate RAASi and MRA in patients with K+ levels above 5 mEq\/L. Additionally, 88.9% of nephrologists and 71.4% of cardiologists agreed that cross-specialty alignment on a serum K+ concentration level (K &amp;gt; 5.5 mEq\/L) is needed to initiate hyperkalaemia treatment. Both cardiologists and nephrologists showed disagreement with the statement on keeping titration in cardiorenal patients with K+ &amp;gt; 5.5 mEq\/L or preserving fruit and vegetable consumption when moderate or severe hyperkalaemia exhibits. This Delphi project pointed out nephrologists' and cardiologists' agreement on hyperkalaemia management in cardiorenal patients; thus, it can help a cross-specialty optimal management of cardiorenal patients, with hyperkalaemia not being an obstacle for disease-optimizing therapy. Novel potassium binding agents can enable guideline-recommended doses of potassium-sparing medication.<\/jats:p>","DOI":"10.1002\/ehf2.15153","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T05:05:33Z","timestamp":1730351133000},"page":"1132-1140","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Delphi Consensus Project to Capture Experts' Opinion on Hyperkalaemia Management Across the Cardiorenal Spectrum"],"prefix":"10.1093","volume":"12","author":[{"given":"Christina","family":"Chrysohoou","sequence":"first","affiliation":[{"name":"Cardiology Department, Hippokration General Hospital , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Marketou","sequence":"additional","affiliation":[{"name":"Cardiology Department, PAGNI University Hospital , Heraklion ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Aktsiali","sequence":"additional","affiliation":[{"name":"Dialysis Unit Department, Nefroiatriki Green , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Griveas","sequence":"additional","affiliation":[{"name":"Nephrology Department, Army Share Fund Hospital of Athens , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"key":"2026021803592819000_ehf215153-bib-0001","first-page":"932","volume-title":"Medical Physiology: A Cellular and Molecular Approach","author":"Binder","year":"2005"},{"key":"2026021803592819000_ehf215153-bib-0002","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/j.jacc.2007.07.067","article-title":"Incidence and predictors of hyperkalemia in patients with heart failure","volume":"50","author":"Desai","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026021803592819000_ehf215153-bib-0003","first-page":"202","article-title":"The clinical and economic burden of hyperkalemia on Medicare and commercial payers","volume":"10","author":"Fitch","year":"2017","journal-title":"Am Health Drug Benefits"},{"key":"2026021803592819000_ehf215153-bib-0004","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/pgmj.2008.072058","article-title":"Understanding the risk of hyperkalaemia in heart failure: role of aldosterone antagonism","volume":"86","author":"Poggio","year":"2010","journal-title":"Postgrad Med J"},{"key":"2026021803592819000_ehf215153-bib-0005","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/MNH.0b013e3283361887","article-title":"Dual blockade of the renin-angiotensin-aldosterone system in cardiac and renal disease","volume":"19","author":"Slagman","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2026021803592819000_ehf215153-bib-0006","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/hypertensionaha.108.128017","article-title":"Hyperkalemia risk in chronic kidney disease: deterrent to the use of aldosterone receptor antagonism or not","volume":"53","author":"Sica","year":"2009","journal-title":"Hypertension"},{"key":"2026021803592819000_ehf215153-bib-0007","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41387-024-00285-3","article-title":"Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial","volume":"14","author":"Podadera-Herreros","year":"2024","journal-title":"Nutr Diabetes"},{"key":"2026021803592819000_ehf215153-bib-0008","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ahj.2024.04.019","article-title":"Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial","volume":"274","author":"Arrigo","year":"2024","journal-title":"Am Heart J"},{"key":"2026021803592819000_ehf215153-bib-0009","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","article-title":"Research guidelines for the Delphi survey technique","volume":"32","author":"Hasson","year":"2000","journal-title":"J Adv Nurs"},{"key":"2026021803592819000_ehf215153-bib-0010","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: how to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"World J Methodol"},{"key":"2026021803592819000_ehf215153-bib-0011","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Qualitative research: consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"key":"2026021803592819000_ehf215153-bib-0012","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1016\/j.arthro.2018.10.004","article-title":"Research pearls: expert consensus based evidence using the Delphi method","volume":"34","author":"Hohmann","year":"2018","journal-title":"Art Ther"},{"key":"2026021803592819000_ehf215153-bib-0013","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0040-1625(91)90002-W","article-title":"An evaluation of Delphi","volume":"40","author":"Woudenberg","year":"1991","journal-title":"Technol Forecast Soc Change"},{"key":"2026021803592819000_ehf215153-bib-0014","doi-asserted-by":"publisher","DOI":"10.7275\/pdz9-th90","article-title":"The Delphi technique: making sense of consensus","volume":"12","author":"Hsu","year":"2007","journal-title":"Pract Assess Res Eval"},{"key":"2026021803592819000_ehf215153-bib-0015","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1046\/j.1365-2648.2003.02537.x","article-title":"The Delphi technique: myths and realities","volume":"41","author":"Powell","year":"2003","journal-title":"J Adv Nurs"},{"key":"2026021803592819000_ehf215153-bib-0016","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1080\/03007995.2020.1816946","article-title":"Delphi, non-RAND modified Delphi, RAND\/UCLA appropriateness method and a novel group awareness and consensus methodology for consensus measurement: a systematic literature review","volume":"36","author":"Jandhyala","year":"2020","journal-title":"Curr Med Res Opin"},{"key":"2026021803592819000_ehf215153-bib-0017","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/13611260500069947","article-title":"The Delphi technique in health sciences education research","volume":"27","author":"de Villiers","year":"2005","journal-title":"Med Teach"},{"key":"2026021803592819000_ehf215153-bib-0018","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.eujim.2015.07.002","article-title":"Delphi methodology in health research: how to do it?","volume":"7","author":"Trevelyan","year":"2015","journal-title":"Eur J Integr Med"},{"key":"2026021803592819000_ehf215153-bib-0019","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-37","article-title":"Stability of response characteristics of a Delphi panel: application of bootstrap data expansion","volume":"5","author":"Akins","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"2026021803592819000_ehf215153-bib-0020","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00457","article-title":"Delphi technique in health sciences: a map","volume":"8","author":"Niederberger","year":"2020","journal-title":"Front Public Health"},{"key":"2026021803592819000_ehf215153-bib-0021","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","article-title":"Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies","volume":"67","author":"Diamond","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"2026021803592819000_ehf215153-bib-0022","volume-title":"The RAND\/UCLA Appropriateness Method User's Manual","author":"Fitch","year":"2001"},{"key":"2026021803592819000_ehf215153-bib-0023","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrneph.2014.168","article-title":"Management of hyperkalaemia in chronic kidney disease","volume":"10","author":"Kovesdy","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"2026021803592819000_ehf215153-bib-0024","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ijcard.2017.07.035","article-title":"Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system","volume":"245","author":"Nilsson","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026021803592819000_ehf215153-bib-0025","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003316","article-title":"Heart failure, diabetes mellitus, and chronic kidney disease","volume":"9","author":"Aguilar","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026021803592819000_ehf215153-bib-0026","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease","volume":"169","author":"Einhorn","year":"2009","journal-title":"Arch Intern Med"},{"key":"2026021803592819000_ehf215153-bib-0027","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors","volume":"21","author":"Epstein","year":"2015","journal-title":"Am J Manag Care"},{"key":"2026021803592819000_ehf215153-bib-0028","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1159\/000442393","article-title":"Prevalence of hyperkalemia in diabetic and non-diabetic patients with chronic kidney disease: a nested case-control study","volume":"42","author":"Loutradis","year":"2015","journal-title":"Am J Nephrol"},{"key":"2026021803592819000_ehf215153-bib-0029","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.phrs.2016.07.032","article-title":"Potassium lowering agents: recommendations for physician and patient education, treatment reappraisal, and serial monitoring of potassium in patients with chronic hyperkalemia","volume":"118","author":"Pitt","year":"2017","journal-title":"Pharmacol Res"},{"key":"2026021803592819000_ehf215153-bib-0030","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","article-title":"Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC heart failure long-term registry","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026021803592819000_ehf215153-bib-0031","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"2026021803592819000_ehf215153-bib-0032","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00125-010-1922-6","article-title":"Increased serum potassium affects renal outcomes: a post hoc analysis of the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) trial","volume":"54","author":"Miao","year":"2011","journal-title":"Diabetologia"},{"key":"2026021803592819000_ehf215153-bib-0033","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"VA NEPHRON-D investigators. Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"Fried","year":"2013","journal-title":"N Engl J Med"},{"key":"2026021803592819000_ehf215153-bib-0034","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/2047487313510678","article-title":"The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial","volume":"21","author":"Heerspink","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2026021803592819000_ehf215153-bib-0035","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026021803592819000_ehf215153-bib-0036","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/2\/1132\/66952978\/eschf_12_2_1132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/2\/1132\/66952978\/eschf_12_2_1132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:59:32Z","timestamp":1771405172000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/2\/1132\/8487953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,10,31]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15153","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,10,31]]},"assertion":[{"value":"2024-07-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}